Skip to content

Paige

Catalog entries using this tag (links open the entry card on its page):

Entries

Virchow

AI Imaging Pathology Foundation Model Paige Microsoft Rare Cancer Self-Supervised
PUBMED_LINK
39080966
FULL NAME
Virchow — Million-Scale Digital Pathology Foundation Model (Paige/Microsoft)
DESCRIPTION
Virchow is the first million-slide foundation model for computational pathology, developed by Paige in collaboration with Microsoft. A 632M-parameter ViT-H model trained using DINOv2 on 1.5 million H&E-stained WSIs from MSKCC (17 tissue types). Demonstrates clinical-grade pan-cancer detection with 0.95 AUC across nine common and seven rare cancers. With less training data, the pan-cancer detector built on Virchow achieves similar performance to tissue-specific clinical-grade models in production, outperforming them on rare cancer variants. Serves as the foundation for Paige's Virchow2 (3M WSIs, multimodal) and Virchow2G (1.8B parameters) models.
URL
https://huggingface.co/paige-ai/Virchow
TITLE
A foundation model for clinical-grade computational pathology and rare cancers detection.
Main citation
Vorontsov E, Bozkurt A, Casson A, Shaikovski G, Zelechowski M, Severson K, Zimmermann E, Hall J, Tenenholtz N, Fusi N, Yang E, Mathieu P, van Eck A, Lee D, Viret J, Robert E, Wang YK, Kunz JD, Lee MCH, Bernhard JH, Godrich RA, Oakley G, Millar E, Hanna M, Wen H, Retamero JA, Moye WA, Yousfi R, Kanan C, Klimstra DS, Rothrock B, Liu S, Fuchs TJ. (2024) A foundation model for clinical-grade computational pathology and rare cancers detection. Nature Medicine, 30(10):2924-2935. doi:10.1038/s41591-024-03141-0. PMID 39080966
ABSTRACT
The analysis of histopathology images with artificial intelligence aims to enable clinical decision support systems and precision medicine. We present Virchow, the largest foundation model for computational pathology to date. In addition to the evaluation of biomarker prediction and cell identification, we demonstrate that a large foundation model enables pan-cancer detection, achieving 0.95 specimen-level AUC across nine common and seven rare cancers. With less training data, the pan-cancer detector built on Virchow achieved similar performance to tissue-specific clinical-grade models in production and outperformed them on some rare variants of cancer.
DOI
10.1038/s41591-024-03141-0